SSRIs and the Silent Side Effects

In a time when mental health issues like depression and anxiety are becoming more recognized, selective serotonin reuptake inhibitors (SSRIs) have significantly changed the landscape of psychiatry. They’ve helped countless people find relief, even saving lives in the process. But there’s a growing conversation about a side effect that often goes unmentioned: sexual dysfunction that might linger long after stopping the medication.

A member of an online support group shared his experience, saying, “I was on Cipralex for two and a half months. During that time, my libido plummeted, I struggled with maintaining an erection, and physical sensations felt muted. After I stopped, some feelings came back, but not all. I learned later that, for some, the effects can last indefinitely. I wish I had been warned; it feels unfair that psychiatrists don’t tell patients about this.”

This post resonated with many others — both men and women using SSRIs. This lingering issue is often termed Post-SSRI Sexual Dysfunction (PSSD), which encompasses various sexual problems persisting after discontinuation of the drug, such as loss of libido, diminished pleasure, and difficulties with arousal or orgasm.

A recent study published in Epidemiology and Psychiatric Sciences suggests that some individuals may not see a return to their previous level of sexual function, even months or years later. This revelation raises challenging questions in the field. Experts are split on whether these effects are genuine or stemming from psychological factors.

Dr. Oren Tene, head of the psychiatric department at Tel Aviv’s Ichilov Hospital, acknowledges that sexual side effects during the use of SSRIs are known. “It’s almost a cruel trade-off,” he states, “as serotonin levels increase and mood improves, sexual function can suffer. Nearly all SSRIs cause this issue, some more so than others. It’s a class-wide impact.”

He elaborates on the symptoms, noting, “We often observe decreased libido and delayed orgasm. Men may face erectile problems, while women might see a drop in lubrication. Ironically, this side effect can be utilized intentionally; SSRIs are sometimes prescribed to men for premature ejaculation. Yet when the delay becomes excessive, it complicates intimacy for couples.”

Dr. Tene further explains that anxiety and depression themselves can dampen sexual function: “I remind my patients that when dealing with depression, good sex often takes a backseat. Sometimes treatment still yields a positive net effect.”

While the adverse effects during treatment are fairly established, what happens post-medication is where debates arise. “That part is controversial,” he continues. “Does sexual dysfunction persist after stopping? Literature increasingly suggests that it can, but studying it is complex, and we don’t have precise numbers.”

One issue might be underreporting, Dr. Tene notes. “Patients often don’t make the connection. Common complaints include reduced sensation, diminished pleasure, and erectile issues. Many feel ‘numb,’ with men typically reporting these effects more, although women often describe them as more severe.”

There’s also some disagreement within the medical community. “A few doctors believe that patients misremember their sexual function from before starting treatment. It’s a challenging area to study, and tracking all possible side effects is nearly impossible.”

Dr. Tene emphasizes the need for caution. “These medications can be life-saving. Listing every rare or debated side effect might deter some from necessary treatment. Patients, however, should have informed consent. It’s a tricky balance.”

If symptoms persist after discontinuation, what can be done? “Unfortunately, we don’t yet have a specific treatment,” he explains. “For most, issues resolve eventually — sometimes in weeks or months, occasionally longer. But we can’t guarantee a fix.”

Yifat Mekler, a sexologist at Rambam Health Care Campus, concurs with Dr. Tene; she believes PSSD is real but often temporary. “In most cases, symptoms resolve in a few weeks to two months. Abruptly stopping antidepressants can prolong the recovery process, as it tends to shock the nervous system.”

Even after the body recovers, the psychological implications can linger. “The interplay between physical and psychological aspects is crucial,” Mekler adds. “Men often develop performance anxiety, concentrating on what might go wrong rather than enjoying the moment. This worry can spike cortisol and adrenaline levels, which suppress arousal — creating a vicious cycle.”

Therapeutic support plays a key role, she believes. “Sex therapy can help men shift away from performance pressures, focusing instead on sensuality and connection. Couples might explore intimacy that isn’t reliant on sexual intercourse. If anxiety lingers, psychiatric support or temporary medications like Viagra can be beneficial.”

The conversation surrounding PSSD reveals a painful dilemma for many: the risk of losing sexual vitality against the urgent need to alleviate depression and anxiety. This has led to deeper mistrust in psychiatry and confusion about the information patients receive — and what’s left unspoken.

However, psychiatrists caution that public fears could have dire consequences. “We encourage anyone who needs these medications to take them,” Dr. Tene insists. “SSRIs can genuinely save lives and change the course of mental illness.”

He also warns against fear-mongering. “When public discussions turn negative towards these treatments, it can deter those in need from seeking help. The truth is, most SSRI users experience only mild or temporary side effects, and the overall benefits generally outweigh the risks.”

His overarching message is one of moderation. “Every medication comes with side effects. The key is balancing the benefits and risks. SSRIs rank among the safest and most effective strategies for treating depression and anxiety. They’ve transformed and saved countless lives. Awareness is crucial, but so is maintaining perspective.”